Skip to main content

Metabolon to Discover, Validate Biomarkers for Takeda

NEW YORK (GenomeWeb News) – Metabolon said today it is using its metabolomic technology to discover therapeutic targets and biomarkers under a collaboration with Takeda Pharmaceutical.

Under the multi-year deal, Metabolon will apply its analytical platform and software to discover and validate targets and to identify novel pharmacodynamic biomarkers for translation into the clinic.

Financial and other terms were not disclosed.

Metabolon's platform measures biochemical changes in samples and maps those changes to corresponding metabolic pathways.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.